Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dr. Khitin Addresses Three Common Myths About Varicose Veins in Lieu of New Study by British Medical Journal
  • USA - English


News provided by

New York Vein Treatment Center

Jul 01, 2015, 13:05 ET

Share this article

Share toX

Share this article

Share toX

New York Vein Treatment Center
New York Vein Treatment Center

New York, New York (PRWEB) July 01, 2015 -- A recently study published by the British Medical Journal has linked the usage of birth control pills and other oral contraceptives to an increased risk of venous insufficiency. In lieu of this study, Dr. Khitin feels it is necessary to address common misconceptions about vein health, particularly varicose veins, which were also focal point of the BMJ study.

Lev M. Khitin, M.D., F.A.C.S., board certified in general, vascular, cardiac, and thoracic surgery, is the founder and president of the New York Vein Treatment Center, a premier medical facility dedicated to complex evaluation and comprehensive treatment of circulatory disorders of lower extremities.

Dr. Khitin is recognized worldwide for his accomplishments in the field of circulation and has pioneered in-office management of vascular diseases with unprecedented results. Utilizing treatment modalities ranging from conservative traditional therapeutic methods to the most advanced medical technologies, Dr. Khitin achieved the highest level of expertise in area of prevention, diagnosis and treatment of pathological conditions affecting venous circulation.

Below, he tackles three common misconceptions about varicose veins and explains why believing these myths can be hazardous to your health.

Link to British Medical Journal study: http://www.bmj.com/content/350/bmj.h2135

Myth #1: “Varicose veins are simply a cosmetic issue and they have nothing to do with my health.”

This is false and ignoring your varicose veins could be dangerous to your health. Despite common believe, varicose veins are not an independent disease, but only a symptom, coincidentally not very common one, of a serious disease called venous insufficiency. People affected by venous insufficiency do always have varicose veins. Rarely, however, varicosities are seen by a naked eye, but they always can be located with duplex ultrasound.

It is not, therefore, varicose veins that can get you in trouble, but rather the disease responsible for their development: venous insufficiency, with its numerous symptoms and dreaded complications. Other signs of venous insufficiency include aches and pains, heaviness and tiredness, muscle cramps, swelling of feet and ankles, formation of spider veins, burning, coldness and itching, fatigue, difficulties walking and particularly standing, restless leg syndrome and many others. Left untreated, the disease progresses and eventually leads to complications, such as infection, blood clots, trophic ulcers, bleeding and even skin cancer.

The one indisputable characteristic of venous diseases is that they are progressively destructive over time, and neglecting them is often the worst choice you can make. By taking care of your varicose veins early upon their appearance, you can prevent their further progression and development of complications, protecting yourself from years of pain and suffering.

Myth #2: Men are not at the risk of developing varicose veins

The number of men suffering from vein diseases has steadily been on the rise over the last decade due to multiple socio-economic reasons.

Such occupations that require prolonged standing, like police officers do, or even prolonged sitting, such as driving a truck, and heavy lifting, such as construction workers are required to do, are especially at high risk of development of venous insufficiency. Some other so-called “risk factors” of venous insufficiency include increased body weight or height, prolonged immobility or even sedentary life style, chronic constipation, enlarged prostate, family history of vein disease and many more.

Finally, men much more likely than women perceive varicose veins, spider veins or any other visible symptom of venous insufficiency, as a purely cosmetic issue, rather than a tiny tip of a huge iceberg hidden from eyes, but unavoidably dangerous. Men, therefore, typically seek medical at more advanced stages of venous disease and are more likely to develop disabling forms of the disease and to suffer from its complications.

Myth #3. “My medical insurance WON’T PAY for my treatment, because my varicose veins are rather cosmetic and not health problem, they are not a real disease and affect only my appearance, but not my well-being."

Since, as we mentioned previously, varicose veins are merely one of many symptoms of serious venous disease, their treatment is nearly always covered by prevailing majority of healthcare insurance plans. Furthermore, because prevention or early intervention preclude development of serious circulatory problems in the future, it is actually more cost effective for insurance companies not only to pay for the treatment, but also to encourage early diagnosis and participation in screening programs.

We recommend visiting a qualified physician specialized in medical management of venous diseases for in depth consultation to explore your options for diagnosis, prophylaxis and treatment of pathological conditions affecting your veins.

Dr. Khitin, New York Vein Treatment Center, http://VeinsTreatment.com, +1 (888) 932-4629 Ext: 117, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.